NCT06661720 2026-04-07
STRIKE
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
Clinical Trials
35 trialsNCT06500455 2026-04-03
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
NRG Oncology
Phase 3 Recruiting
NCT05738694 2026-03-17
Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma
Sun Yat-sen University
Phase 3 Recruiting
NCT06959433 2026-02-27
Lu-177 PSMA Treatment in Cell Renal Carcinoma
Ankara University
Phase 3 Not yet recruiting
NCT07092566 2026-01-20
R.E.C.K vs Exparel in Robotic Nephrectomy
Wake Forest University Health Sciences
Phase 3 Recruiting
NCT06726421 2026-01-15
STROKER
Sun Yat-sen University
Phase 3 Recruiting
NCT01224288 2025-11-10
Dynamic Contrast Enhancement Computed Tomography for Evaluating Tumor Perfusion in Patients With Metastatic Renal Cell Carcinoma Receiving Targeted Therapies: Renal Cell Carcinoma (RCC) Scramble
M.D. Anderson Cancer Center
Phase 3 Active not recruiting
NCT07165418 2025-09-10
A Comparison of Vorolanib Tablets Combined With Everolimus Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma Who Have Progressed After Treatment With Immunotherapy Monotherapy or in Combination With TKI
Peking University Cancer Hospital & Institute
Phase 3 Not yet recruiting
NCT00930033 2025-09-05
CARMENA
Assistance Publique - Hôpitaux de Paris
Phase 3 Completed
NCT05796973 2025-06-27
MOVES
Tampere University Hospital
Phase 3 Recruiting
NCT04588246 2025-06-06
Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery
NRG Oncology
Phase 3 Terminated
NCT05078047 2025-06-05
MOIO
UNICANCER
Phase 3 Recruiting
NCT05219318 2025-06-04
SPICI
University Hospital, Bordeaux
Phase 3 Active not recruiting
NCT03013946 2025-02-14
PREPARE
AIO-Studien-gGmbH
Phase 3 Terminated
NCT06364631 2025-01-16
CARE1
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Recruiting
NCT00606866 2023-11-29
MRI
University of Chicago
Phase 3 Completed
NCT06146777 2023-11-29
Multi-classifier System for Stratifying Stage III Papillary Renal Cell Carcinoma of Receiving Adjuvant Therapy
First Affiliated Hospital, Sun Yat-Sen University
Phase 3 Not yet recruiting
NCT04764487 2022-05-03
AxiPRO
Weprom
Phase 3 Unknown
NCT03408652 2021-10-22
MOSCAR
Centre Leon Berard
Phase 3 Terminated
NCT03288532 2020-09-07
RAMPART
University College, London
Phase 3 Recruiting
NCT02928692 2020-01-28
MAPOCD
RenJi Hospital
Phase 3 Unknown
NCT00540969 2018-11-21
Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone Metastases
Alliance for Clinical Trials in Oncology
Phase 3 Terminated
NCT01265810 2017-11-13
COMTT
Impaqtt Foundation
Phase 3 Completed
NCT01613846 2017-04-20
Phase III Sequential Open-label Study to Evaluate the Efficacy and Safety of Sorafenib Followed by Pazopanib Versus Pazopanib Followed by Sorafenib in the Treatment of Advanced / Metastatic Renal Cell Carcinoma (SWITCH-II)
Technical University of Munich
Phase 3 Completed
NCT00003126 2017-01-04
Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer
Loyola University
Phase 3 Completed
NCT00072046 2016-07-06
Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00732914 2014-04-23
Sequential Study to Treat Renal Cell Carcinoma
Sponsor GmbH
Phase 3 Completed
NCT00502034 2013-07-10
Low-dose IL-2 Plus IFN-alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma.
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 3 Completed
NCT01481870 2013-02-25
CROSS-J-RCC
Yamagata University
Phase 3 Unknown
NCT00416429 2012-09-26
Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer
Centre Leon Berard
Phase 3 Completed
NCT00416871 2012-09-26
Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer
Centre Leon Berard
Phase 3 Completed
NCT00311467 2012-05-16
Combined Treatment With Capecitabine and Immunotherapy Versus Immunotherapy Alone in Advanced Renal Cell Carcinoma
Central European Cooperative Oncology Group
Phase 3 Terminated
NCT00478114 2011-08-29
Efficacy and Safety of Sorafenib in Advanced Renal Cell Carcinoma (RCC)
Mahidol University
Phase 3 Completed
NCT00869011 2009-12-23
Exercise for Patients With Renal Cell Cancer Receiving Sunitinib
Charite University, Berlin, Germany
Phase 3 Unknown
NCT00291369 2006-02-16
Cytokines in Patients With Metastatic Renal Cell Carcinoma of Intermediate Prognosis
Centre Leon Berard
Phase 3 Completed